Study identifier:D5630R00002
ClinicalTrials.gov identifier:NCT04968652
EudraCT identifier:N/A
CTIS identifier:N/A
Evaluation of the Simplified Diagnosis Tool for Chinese IBS-C (irritable bowel syndrome with constipation) patients
irritable bowel syndrome with constipation
N/A
No
-
All
327
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2022 by AstraZeneca
AstraZeneca
The First Affiliated Hospital, Sun Yat-sen University, The Third Affiliated Hospital, Sun Yat-sen University, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, The First Affiliated Hospital of Nanchang University, Henan Provincial People's Hospital, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Wuhan Union Hospital of China, Peking University First Hospital, The First Affiliated Hospital of Anhui Medical University, Shengjing Hospital
No locations available
Arms | Assigned Interventions |
---|---|
IBS-C Group Result of ROME VI marked as ‘IBS-C’. | - |
Non IBS-C Group Result of ROME VI marked as ‘Non IBS-C’ | - |